Who We Are
Brian G. Kelly
Brian G. Kelly has been a Director of Activision since July 1995. He has served as Chairman of the Company since October 2013 and as Co-Chairman since October 1998. He previously served as President of the Company from July 1997 to October 1998, and Chief Operating Officer of the Company from July 1995 to October 1998. He also served as Chief Financial Officer of the Company from February 1991 until July 1997, and Secretary of the Company from May 1991 until October 1997. Mr. Kelly holds a law degree from Fordham Law School and a B.A. degree in accounting from Rutgers University, and was a certified public accountant.
Mr. Kelly is the Co-Founder of The Call of Duty Endowment (“CODE”). CODE is a non-profit public benefit corporation which helps service members transition to civilian careers after their military service.
Mr. Kelly is the Founder and Chairman of the Board of the Juvenile Diabetes Cure Alliance (“JDCA”). The JDCA is a novel and innovative non-profit that advocates a businesslike approach to type 1 diabetes cure research where donors are treated as shareholders. The JDCA acts like a Wall Street sell-side analyst studying, analyzing and commenting on non-profit diabetes research foundations/organizations, and provides advice to major cure research donors on how to make their contributions most effective.
Senior Adviser to Board of Trustees
Joseph Tuite is the Chief Investment Officer of West Side Avenue Holdings and Eureka Investments. Joe holds a BA in finance from Villanova University.
Robert Chadwick, CPA
Senior Adviser to Board of Trustees
Bob Chadwick has over 30 years of experience as a CPA, heading his own practice for 25 years in central New Jersey. With a vast range of clients from local business owners to large corporations, Chadwick and Company serves the immediate metropolitan area of NY, NJ and PA, as well as various clients nationwide.
Philip J. Shaw
Philip Shaw has led the JDCA since March of 2012. Prior to that, Mr. Shaw worked for both Kraft Foods and General Mills in a range of marketing and general management roles. Mr. Shaw spent the majority of his career in the United States, but also held expatriate market leadership roles in Asia. Phil has an MBA from Georgetown University and a BA from Brandeis University.
David M. Fischer
David Fischer is a research associate for the JDCA, overseeing research, writing, and editing for publications. Prior to joining the JDCA, David has over 5 years experience writing and editing for both print and online publications, most of which focused on healthcare topics that involved working closely with industry professionals. David holds a BA from the University of Milwaukee.
Rob leads the JDCA's Advocacy and Outreach efforts. Diagnosed with Type 1 as an adult in 2008, Rob is committed to devoting his time to finding a cure. Prior to joining the JDCA, Rob held various sales and marketing roles throughout his career working in a variety of industries including non-profit, sports, consumer goods and entertainment. He is a graduate of Hamilton College in Clinton, NY.
Alliance Adviser & Past Associate
Nick Masercola is a writer and marketer with experience in a variety of industries, including print journalism, non-profit advocacy, and New York Theatre. He currently works at Finn Partners as a publicist specializing in books and health media. Prior to Finn, Nick served as a Marketing and Communications Manager with the Juvenile Diabetes Cure Alliance. In his spare time, Nick has co-written and produced award winning off-Broadway theater. Nick holds a BA from Hofstra University.
Olivia Picard is a student at The New School pursuing a BA in dance with a minor in psychology. Olivia was diagnosed with Type 1 in 2007, and she has made it her personal mission to never let diabetes control her life. She is thrilled to be part of the team at the JDCA and hopes that she can have a positive influence on the T1D community.
Elisabeth Fuentes is a student at Fordham University pursuing a BA in psychology on the pre-medical track. Elisabeth was diagnosed with Type 1 when she was two years old, and later decided to dedicate her time to medicine and helping others like herself. She is grateful to be a member of the JDCA team, helping them in their mission to ensure better lives for Type 1’s.